Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-006574-21Phase 4Completed
Phase 4, randomised trial of frovatriptan and zolmitriptan in migraine (2 arms), sponsored by Laboratori Guidotti. Primary endpoint: Patient preference for first or second treatment. Started Jun 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-006574-21.